US doctors report hearing impairment cases linked to eye disease treatment
American doctors have documented 84 hearing-related adverse events in patients taking teprotumumab (Tepezza) for thyroid eye disease, a treatment which...
American doctors have documented 84 hearing-related adverse events in patients taking teprotumumab (Tepezza) for thyroid eye disease, a treatment which...
Ophthalmic device distributor BOC Instruments has received TGA registration for its new RetiCam 3100 Plus wide-field fundus camera. In a...
An Irish study has concluded that children taking nightly 0.05% atropine eye drops experienced less myopia progression than those receiving...
Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited